Join Humacyte for a virtual KOL event, featuring Charles Fox, MD (University of Maryland School of Medicine), Rishi Kundi MD, RPVI, FACS, FSVS (University of Maryland School of Medicine), and YingWei Lum, MD, MPH (Johns Hopkins School of Medicine), who will discuss the unmet medical need and current treatment landscape for vascular trauma, including urgent arterial repair after extremity vascular trauma.

The event will highlight case studies evaluating Humacyte’s acellular tissue engineered vessel (ATEV™) product candidate as a treatment for vascular trauma, including the positive long-term results from a humanitarian program conducted in Ukraine. The ATEV is an investigational, first-in-class bioengineered human tissue that is designed to be a universally implantable vascular conduit for use in arterial replacement and repair.

A live question and answer session will follow the formal presentations.